RTHP-14. TREATMENT RESULTS OF STEREOTACTIC RADIOTHERAPY AND BEVACIZUMAB (SRT-Bv) FOR RECURRENT GLIOBLASTOMA

CONCLUSION:SRT with bevacizumab is a safe and considerable treatment option for recurrent glioblastoma.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Yasuda, T., Nitta, M., Maruyama, T., Tsuduki, S., Muragaki, Y., Kawamata, T. Tags: RADIATION THERAPY Source Type: research